Effects of pirmenol on action potentials and membrane currents in single atrial myocytes.

Electrophysiological effects of pirmenol hydrochloride (pirmenol) were investigated in single atrial myocytes obtained from rabbit and guinea-pig hearts by using a whole-cell clamp technique. Under current clamp conditions, pirmenol (2-30 microM) prolonged action potential duration in a concentration-dependent manner without affecting resting membrane potential in rabbit atrial myocytes. However, in the presence of 4-aminopyridine (4 mM), pirmenol (10 microM) failed to prolong the action potential duration further. Pirmenol also suppressed acetylcholine-induced hyperpolarization and action potential duration shortening, resulting in a significant prolongation of the action potential duration in the presence of acetylcholine. Under voltage clamp conditions, pirmenol (1-1000 microM) inhibited transient outward current (I(to)) in a concentration-dependent manner. The concentration for half-maximal inhibition (IC50) of pirmenol on I(to) was about 18 microM. Pirmenol did not show the use and frequency dependent inhibition of I(to). The voltage dependence of the steady-state inactivation of I(to) and the recovery from inactivation were not significantly affected by pirmenol. Pirmenol accelerated the inactivation of I(to) and blocked I(to) as an exponential function of time, consistent with a time-dependent open channel blockade. Pirmenol (30 microM) did not affect the inwardly rectifying K+ current significantly, but it decreased the voltage-dependent L-type Ca2+ current by about 20%. In guinea-pig atrial myocytes, both acetylcholine and adenosine induced a specific K+ current activated by GTP-binding proteins. Pirmenol suppressed both the acetylcholine- and adenosine-induced K+ current effectively. The IC50 of pirmenol for acetylcholine- and adenosine-induced current was about 1 and 8 microM, respectively. The present results suggest that pirmenol prolongs the action potential duration by primarily inhibiting the transient outward current in atrial myocytes. In addition, since pirmenol inhibits acetylcholine- and adenosine-induced K+ current, pirmenol may effectively prolong the action potential duration in atrial myocytes under various physiological conditions as in the whole heart or ischemia.

[1]  E. Williams.  A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs , 1984 .

[2]  M. Omata,et al.  Flecainide inhibits the transient outward current in atrial myocytes isolated from the rabbit heart. , 1995, The Journal of pharmacology and experimental therapeutics.

[3]  Y. Kurachi,et al.  Anti‐Cholinergic Effects of Quinidine, Disopyramide, and Procainamide in Isolated Atrial Myocytes: Mediation by Different Molecular Mechanisms , 1989, Circulation research.

[4]  I. Dukes,et al.  Electrophysiological and Cardiovascular Effects of Pirmenol, a New Class 1 Antiarrhythmic Drug , 1986, Journal of cardiovascular pharmacology.

[5]  M. Omata,et al.  Regional differences in transient outward current density and inhomogeneities of repolarization in rabbit right atrium. , 1995, Circulation.

[6]  M. Morad,et al.  Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells. , 1990, The Journal of pharmacology and experimental therapeutics.

[7]  Allessie,et al.  Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. , 1977, Circulation research.

[8]  J. Hasegawa,et al.  Effects of pirmenol hydrochloride on the spontaneous action potentials and membrane current systems of rabbit sinoatrial node cells. , 1988, Journal of Electrocardiology.

[9]  Two distinct types of inwardly rectifying K+ channels in bull‐frog atrial myocytes. , 1990, The Journal of physiology.

[10]  D. Escande,et al.  Comparative effects of three class I antiarrhythmic drugs on plateau and pacemaker currents of sheep cardiac Purkinje fibres. , 1988, Cardiovascular research.

[11]  Y. Hara,et al.  Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Different molecular mechanisms. , 1995, Circulation.

[12]  R. Berne,et al.  The cardiac effects of adenosine. , 1989, Progress in cardiovascular diseases.

[13]  W. Osterrieder,et al.  Inhibition of the myocardial Ca2+ inward current by the class 1 antiarrhythmic agent, cibenzoline , 1986, British journal of pharmacology.

[14]  M. Hiraoka,et al.  Effects of quinidine on plateau currents of guinea-pig ventricular myocytes. , 1986, Journal of molecular and cellular cardiology.

[15]  E. Pritchett,et al.  Pirmenol, A New Antiarrhythmic Agent: Initial Study of Efficacy, Safety and Pharmacokinetics , 1982, Circulation.

[16]  B. Fermini,et al.  Differences in rate dependence of transient outward current in rabbit and human atrium. , 1992, The American journal of physiology.

[17]  Y. Kurachi,et al.  Effects of anions on the G protein-mediated activation of the muscarinic K+ channel in the cardiac atrial cell membrane. Intracellular chloride inhibition of the GTPase activity of GK , 1992, The Journal of general physiology.

[18]  M. Rosen,et al.  Effects of pirmenol HCl on electrophysiologic properties of cardiac Purkinje fibers. , 1980, European journal of pharmacology.

[19]  H. R. Kaplan,et al.  Preclinical pharmacology of pirmenol. , 1987, The American journal of cardiology.

[20]  K. Hashimoto,et al.  Antiarrhythmic plasma concentrations of pirmenol on canine ventricular arrhythmias. , 1988, Japanese journal of pharmacology.

[21]  M. Nieminen,et al.  Pirmenol in the termination of paroxysmal supraventricular tachycardia. , 1987, The American journal of cardiology.

[22]  W. Giles,et al.  Quinidine-induced inhibition of transient outward current in cardiac muscle. , 1987, The American journal of physiology.

[23]  G. Moe,et al.  On the multiple wavelet hypothesis o f atrial fibrillation. , 1962 .

[24]  M. Nieminen,et al.  Conversion of paroxysmal atrial fibrillation to sinus rhythm by intravenous pirmenol. , 1987, The American journal of cardiology.

[25]  W. Giles,et al.  Comparison of potassium currents in rabbit atrial and ventricular cells. , 1988, The Journal of physiology.

[26]  D P Zipes,et al.  Radiofrequency catheter ablation of the atria reduces inducibility and duration of atrial fibrillation in dogs. , 1995, Circulation.

[27]  H. Yamamoto,et al.  Effects of CM7857, a Derivative of Disopyramide, on Electrophysiologic Properties of Canine Purkinje Fibers and Inotropic Properties of Canine Ventricular Muscle , 1986, Journal of cardiovascular pharmacology.

[28]  H. Nakaya,et al.  Frequency- and voltage-dependent depression of maximum upstroke velocity of action potentials by pirmenol in guinea pig ventricular muscles. , 1988, Japanese journal of pharmacology.

[29]  W. Giles,et al.  Regulation of spontaneous opening of muscarinic K+ channels in rabbit atrium. , 1991, The Journal of physiology.

[30]  M. Allessie,et al.  Length of Excitation Wave and Susceptibility to Reentrant Atrial Arrhythmias in Normal Conscious Dogs , 1988, Circulation research.

[31]  A. Coulombe,et al.  Effect of tetrodotoxin on action potentials of the conducting system in the dog heart. , 1979, The American journal of physiology.

[32]  H. R. Kaplan,et al.  CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent. , 1980, Journal of Pharmacology and Experimental Therapeutics.

[33]  A. Newby,et al.  Absolute rates of adenosine formation during ischaemia in rat and pigeon hearts. , 1988, The Biochemical journal.

[34]  W. Giles,et al.  Contributions of a transient outward current to repolarization in human atrium. , 1989, The American journal of physiology.